Convatec Group PLC
CTEC: XLON (GBR)
| Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
|---|---|---|---|
| LOCK|&C | LOCK|<b<WX | LOCK|qK>@Y> |
Convatec Earnings: Solid Mid-Single-Digit Growth, Despite Reimbursement Headwinds
Convatec reported abbreviated third-quarter results that featured 5% revenue growth year over year, supported by mid-single-digit growth from advanced wound care and double-digit increases from the smaller infusion care product line.
